Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT05293340
Other study ID # C2021-0068
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date March 31, 2022
Est. completion date January 31, 2023

Study information

Verified date November 2023
Source Sansum Diabetes Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hispanic/Latino adults in the United States (U.S.) bear a disproportionate burden of type 2 diabetes (T2D). Dietary changes, facilitated by increased access and adherence to healthy foods, are necessary. In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic control in Hispanic/Latino (predominantly of Mexican origin) adults with or at-risk of T2D before and after receiving free avocados for 12 weeks. Beyond CGM-measured glycemic control, wearable activity and sleep monitors, physical exams, laboratory analyses, and questionnaires/logs will be used to track the impact of free avocado vouchers. The findings are anticipated to help clinicians provide new information to support positive behavior change to reduce the risk of T2D or progression from pre-diabetes to T2D and make it easier for patients to access healthier food, potentially leading to improved health.


Description:

In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic control in Hispanic/Latino adults with and at-risk of T2D before and after receiving free avocado vouchers. The impact of using CGM to determine the effect of improving access to avocados on glycemic profiles and food related-behaviors for Hispanic/Latino adults with or at risk of T2D is not known at present. To address this need, increased avocado consumption will be combined with CGM to assess post-prandial glucose responses. This is based on evidence showing that one half of a Hass avocado at lunch is associated with increased satisfaction and reduced desire to eat over the subsequent 3-5 hours in overweight or obese adults. For CGM, there is a lack of prospective data on the relationship between derived metrics and complications for adults with non-insulin treated T2D or at-risk of T2D, but glucose profiles from non-diabetic subjects suggest very tight glycemic control, with only brief postprandial excursions >140 mg/dL. Cross-sectional data suggests more time spent between 140 and 180 mg/dl comparing predominantly Mexican American adults at risk of T2D to adults with pre-T2D and to adults with diagnosed T2D. Further, in a study examining the thresholds for CGM at which vascular disease can be detected, Lu and colleagues reported time in ranges above 140 mg/dL was associated with abnormal values for retinopathy and carotid intima-medial thickness, a measure of macrovascular disease risk. Hence, the focus in this study will be time in range between 140 and 180 mg/dl between 6 am and 12 am (waking hours).


Recruitment information / eligibility

Status Terminated
Enrollment 50
Est. completion date January 31, 2023
Est. primary completion date January 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Adults = 18 years of age at enrollment. 2. Self-reported Hispanic/Latino heritage. 3. Self-reported diagnosis of T2D or self-reported as at risk for developing T2D using the American Diabetes Association diabetes risk assessment tool [25]. Exclusion Criteria: 1. Use of insulin 2. Pregnancy 3. Any active clinically significant disease or disorder which in the investigator's opinion could interfere with participation in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Avocado Vouchers
Food as Medicine to demonstrate clinically meaningful benefits for underserved communities. Avocados are fruits with fats, fiber, micronutrients, and bioactive phytochemicals.

Locations

Country Name City State
United States Sansum Diabetes Research Institute Santa Barbara California

Sponsors (2)

Lead Sponsor Collaborator
Sansum Diabetes Research Institute Hass Avocado Board

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time in range (TIR) between 140 and 180 mg/dL [TIR (140-180)]- Change from Prior to Intervention, to Final Two Weeks of Intervention TIR (140 -180 mg/dL) between 6 am and 12 am (waking hours). Prior to Intervention (Week 0), and During Final 2 Weeks of Intervention (Week 13 or 14)
Secondary Waist Circumference- Change from Enrollment Visit to Study Conclusion Visit Changes in waist circumference At Enrollment Visit and at 14 weeks from Enrollment Visit
Secondary Blood Pressure- Diastolic and Systolic- Change from Enrollment Visit to Study Conclusion Visit Changes in blood pressure At Enrollment visit and at 14 weeks from Enrollment Visit
Secondary HbA1c- Change from Enrollment Visit to Study Conclusion Visit Changes in HbA1c At Enrollment Visit and at 14 weeks from Enrollment Visit
Secondary Insulin resistance- Change from Enrollment Visit to Study Conclusion Visit Changes in Insulin Resistance At Enrollment visit and at 14 weeks from enrollment visit
Secondary Lipids- Change from Enrollment Visit to Study Conclusion Visit Changes in lipids At enrollment visit and at 14 weeks from enrollment visit
Secondary Prescribed medicines for T2D and/or hypertension- Change from Enrollment Visit to Study Conclusion Visit Changes in prescribed medicines for T2D and/or hypertension At enrollment visit and at 14 weeks from enrollment visit
Secondary Self-reported sleep, mood, and pain via 100 mm Likert scale questionnaire- Change from Enrollment, and to Final Visit Changes in self-reported sleep, mood, and pain (Best to Worst) At enrollment visit, and at 14 weeks from enrollment visit
Secondary Self-reported Food security via United States Dept. of Agriculture U.S. Household Food Security Survey Module: Six-Item Short Form - Change from Enrollment, and at Final Visit Changes in Food Security At enrollment visit, and at 14 weeks from enrollment visit
Secondary Depression via the Depression, Anxiety and Stress Scale (DASS-21) Change in depression score (0-42), with higher scores indicating higher levels of depression At enrollment visit, and at 14 weeks from enrollment visit
Secondary Anxiety via the Depression, Anxiety and Stress Scale (DASS-21) Change in anxiety score (0-42), with higher scores indicating higher levels of anxiety At enrollment visit, and at 14 weeks from enrollment visit
Secondary Stress via the Depression, Anxiety and Stress Scale (DASS-21) Change in stress score (0-42), with higher scores indicating higher levels of stress At enrollment visit, and at 14 weeks from enrollment visit
Secondary Change in Eating Self-Efficacy Scale (ESES) score Change in Eating Self-Efficacy Scale (ESES) mean score (25-175), with higher scores indicating lower eating self-efficacy. Prior to intervention (Week 0), and during final 2 weeks of intervention (Week 13 or 14)
Secondary Change in Self-Report Habit Index (SRHI) score Change in Self-Report Habit Index (SRHI) mean score (1-7), with higher scores indicating stronger habits. Prior to intervention (Week 0), and during final 2 weeks of intervention (Week 13 or 14)
Secondary Change in Self-Regulation of Eating Questionnaire (SREBQ) score Change in Self-Regulation of Eating Behaviour Questionnaire (SREBQ) mean score (1-5), with higher scores indicating better self-regulation of eating behavior. Prior to intervention (Week 0), and during final 2 weeks of intervention (Week 13 or 14)
Secondary Physical Activity- Daily step count, Changes from first to final Fitbit application Physical Activity- Daily step count averaged over =14 days, Change from first Fitbit application (pre-intervention) to second Fitbit application (in final 14 days of intervention). First Fitbit application (pre-intervention) to second Fitbit application (in final 14 days of intervention)
Secondary Sleep Duration Change in Sleep Duration (in minutes) averaged over =14 days First Fitbit application (pre-intervention) to second Fitbit application (in final 14 days of intervention)
Secondary Secondary Continuous Glucose Monitoring Endpoints- Time in Range (TIR) 140-180 mg/dl, Waking Hours Change in TIR between 140 and 180 mg/dL [TIR (140-180)] between 6 am and 12 am (waking hours), averaged over =14 days from first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention). first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention).
Secondary Secondary Continuous Glucose Monitoring Endpoints- Average Glucose Change in Average Glucose averaged over =14 days from first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention). first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention).
Secondary Secondary Continuous Glucose Monitoring Endpoints- Time in Range (TIR) 70-180 mg/dL Change in TIR 70-180 mg/dL averaged over =14 days from first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention). first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention).
Secondary Secondary Continuous Glucose Monitoring Endpoints- Time >180 mg/dL Change in time >180 mg/dL averaged over =14 days from first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention). first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention).
Secondary Secondary Continuous Glucose Monitoring Endpoints- Time <70 mg/dL Change in time <70 mg/dL averaged over =14 days from first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention). first CGM application (pre-intervention) to second CGM application (in final 14 days of intervention).
Secondary Adherence to the intervention Adherence to the intervention as measured via the daily avocado consumption log (DACL) 12-week intervention monitoring period running weeks 2-14
Secondary Acceptability of the intervention Acceptability of the intervention as measured by the weekly avocado acceptability questionnaire (WAAQ) 12-week intervention monitoring period running weeks 2-14
Secondary Regression analysis between avocado adherence measured as an average number of avocados consumed as reported via the daily avocado consumption log (DACL) and personality traits assessed via the Mini International Personality Item Tool. Each participant will fill out the Mini International Personality Item Tool (Mini-IPIP) at the start of the study. It comprises 20 items and assesses the five personality factors (Extraversion, Agreeableness, Conscientiousness, Neuroticism, and Imagination). Scoring includes computing the mean score for each factor with a value ranging from 1 to 5 (very inaccurate to very accurate). Avocado adherence measured as the mean of the number of avocados consumed as reported via the daily avocado consumption log (DACL) will be computed. A regression analysis will be performed between the mean of the number of avocados consumed as the response variable and the five personality factors scores as the predictor variables. The coefficients of the regression analysis will be studied to evaluate if personality traits can predict avocado adherence. Average over 12 weeks
Secondary Regression analysis between the average number of avocados consumed as reported via the daily avocado consumption log (DACL) and motives underlying the selection of food assessed by the Food Choice Questionnaire (FCQ) Each participant will fill out the Food Choice Questionnaire at the start of the study. It comprises 36 items and assesses the importance of 9 types of motives underlying food selection (Health, Mood, Convenience, Sensory Appeal, Natural Content, Price, Weight Control, Familiarity and Ethical Concern). Scoring includes computing the mean score for each type of motive ranging from 1-4 with higher values indicating higher importance. Avocado adherence measured as the mean of the number of avocados consumed as reported via the daily avocado consumption log (DACL) will be computed. A regression analysis will be performed between the mean of the number of avocados consumed as the response variable and the scores of the 9 types of motives underlying food selection as the predictor variables. The coefficients of the regression analysis will be studied to evaluate if food choice motives can predict avocado adherence. Average over 12 weeks
Secondary Regression analysis between average composite acceptability score on the weekly Avocado Acceptability Questionnaire and Personality traits assessed via the Mini International Personality Item Tool. Each participant will fill out the Mini International Personality Item Tool at the start of the study. It comprises 20 items and assesses the five personality factors (Extraversion, Agreeableness, Conscientiousness, Neuroticism, and Imagination). Scoring includes computing the mean score for each factor with a value ranging from 1 to 5 (very inaccurate to very accurate). The mean of the composite acceptability score on the weekly Avocado Acceptability Questionnaire (average taken over 12 weeks) will be computed. A regression analysis will be performed between the mean of the composite acceptability score as the response variable and the five personality factors scores as the predictor variables. The coefficients of the regression analysis will be studied to evaluate if personality traits can predict acceptability score. Average over 12 weeks
Secondary Regression analysis between average composite acceptability score on the weekly Avocado Acceptability Questionnaire and motives underlying the selection of food assessed by the Food Choice Questionnaire (FCQ) Each participant will fill out the Food Choice Questionnaire at the start of the study. It comprises 36 items and assesses the importance of 9 types of motives underlying food selection (Health, Mood, Convenience, Sensory Appeal, Natural Content, Price, Weight Control, Familiarity, and Ethical Concern). Scoring includes computing the mean score for each type of motive ranging from 1-4 with higher values indicating higher importance. The mean of the composite acceptability score on the weekly Avocado Acceptability Questionnaire (average taken over 12 weeks) will be computed. A regression analysis will be performed between the mean of the composite acceptability score as the response variable and the scores of the 9 types of motives underlying food selection as the predictor variables. The coefficients of the regression analysis will be studied to evaluate if food choice motives can predict acceptability score. Average over 12 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2